These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1570844

  • 1. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers.
    Klein CJ, Coovert DD, Bulman DE, Ray PN, Mendell JR, Burghes AH.
    Am J Hum Genet; 1992 May; 50(5):950-9. PubMed ID: 1570844
    [Abstract] [Full Text] [Related]

  • 2. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin.
    Thanh LT, Nguyen TM, Helliwell TR, Morris GE.
    Am J Hum Genet; 1995 Mar; 56(3):725-31. PubMed ID: 7887428
    [Abstract] [Full Text] [Related]

  • 3. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.
    Winnard AV, Mendell JR, Prior TW, Florence J, Burghes AH.
    Am J Hum Genet; 1995 Jan; 56(1):158-66. PubMed ID: 7825572
    [Abstract] [Full Text] [Related]

  • 4. Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group.
    Burrow KL, Coovert DD, Klein CJ, Bulman DE, Kissel JT, Rammohan KW, Burghes AH, Mendell JR.
    Neurology; 1991 May; 41(5):661-6. PubMed ID: 1781820
    [Abstract] [Full Text] [Related]

  • 5. PCR and immunocytochemical analyses of dystrophin-positive fibers in Duchenne muscular dystrophy.
    Uchino M, Tokunaga M, Mita S, Uyama E, Ando Y, Teramoto H, Miike T, Ando M.
    J Neurol Sci; 1995 Mar; 129(1):44-50. PubMed ID: 7751844
    [Abstract] [Full Text] [Related]

  • 6. Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein.
    Vainzof M, Zubrzycka-Gaarn EE, Rapaport D, Passos-Bueno MR, Pavanello RC, Pavanello-Filho I, Zatz M.
    J Neurol Sci; 1991 Feb; 101(2):141-7. PubMed ID: 1709683
    [Abstract] [Full Text] [Related]

  • 7. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K, Beggs AH, Honda H, Ito S, Ishiura S, Tsukahara T, Ishiguro T, Eguchi C, Orimo S, Arikawa E.
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [Abstract] [Full Text] [Related]

  • 8. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
    Sahashi K, Ibi T, Suoh H, Nakao N, Tashiro M, Marui K, Arahata K, Sugita H.
    Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
    [Abstract] [Full Text] [Related]

  • 9. Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.
    Sherratt TG, Vulliamy T, Dubowitz V, Sewry CA, Strong PN.
    Am J Hum Genet; 1993 Nov; 53(5):1007-15. PubMed ID: 8213828
    [Abstract] [Full Text] [Related]

  • 10. Dystrophin or a "related protein" in Duchenne muscular dystrophy?
    Nicholson LV, Johnson MA, Davison K, O'Donnell E, Falkous G, Barron M, Harris JB.
    Acta Neurol Scand; 1992 Jul; 86(1):8-14. PubMed ID: 1519480
    [Abstract] [Full Text] [Related]

  • 11. Dystrophin analysis in the diagnosis of childhood muscular dystrophy: an immunohistochemical study of 75 cases.
    Jay V, Becker LE, Ackerley C, Ray P.
    Pediatr Pathol; 1993 Jul; 13(5):635-57. PubMed ID: 8247961
    [Abstract] [Full Text] [Related]

  • 12. Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy.
    Muntoni F, Mateddu A, Cianchetti C, Marrosu MG, Clerk A, Cau M, Congiu R, Cao A, Melis MA.
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):26-31. PubMed ID: 8429320
    [Abstract] [Full Text] [Related]

  • 13. Somatic mosaicism for a deletion of the dystrophin gene in a carrier of Becker muscular dystrophy.
    Voit T, Neuen-Jacob E, Mahler V, Jauch A, Cremer M.
    Eur J Pediatr; 1992 Feb; 151(2):112-6. PubMed ID: 1537352
    [Abstract] [Full Text] [Related]

  • 14. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
    Le Thiet Thanh, Nguyen Thi Man, Hori S, Sewry CA, Dubowitz V, Morris GE.
    Am J Med Genet; 1995 Aug 28; 58(2):177-86. PubMed ID: 8533812
    [Abstract] [Full Text] [Related]

  • 15. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
    Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Müller CR, Lindlöf M, Kaariainen H, de la Chapellet A, Kiuru A, Savontaus ML, Gilgenkrantz H, Récan D, Chelly J, Kaplan JC, Covone AE, Archidiacono N, Romeo G, Liechti-Gailati S, Schneider V, Braga S, Moser H, Darras BT, Murphy P, Francke U, Chen JD, Morgan G, Denton M, Greenberg CR, Wrogemann K, Blonden LA, van Paassen MB, van Ommen GJ, Kunkel LM.
    Am J Hum Genet; 1989 Oct 28; 45(4):498-506. PubMed ID: 2491009
    [Abstract] [Full Text] [Related]

  • 16. Expression of dystrophin-associated proteins in dystrophin-positive muscle fibers (revertants) in Duchenne muscular dystrophy.
    Matsumura K, Tomé FM, Collin H, Leturcq F, Jeanpierre M, Kaplan JC, Fardeau M, Campbell KP.
    Neuromuscul Disord; 1994 Mar 28; 4(2):115-20. PubMed ID: 7516752
    [Abstract] [Full Text] [Related]

  • 17. Immunohistological evidence for second or somatic mutations as the underlying cause of dystrophin expression by isolated fibres in Xp21 muscular dystrophy of Duchenne-type severity.
    Wallgren-Pettersson C, Jasani B, Rosser LG, Lazarou LP, Nicholson LV, Clarke A.
    J Neurol Sci; 1993 Aug 28; 118(1):56-63. PubMed ID: 8229051
    [Abstract] [Full Text] [Related]

  • 18. Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations.
    Darras BT, Blattner P, Harper JF, Spiro AJ, Alter S, Francke U.
    Am J Hum Genet; 1988 Nov 28; 43(5):620-9. PubMed ID: 2903663
    [Abstract] [Full Text] [Related]

  • 19. A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient.
    Prior TW, Papp AC, Snyder PJ, Burghes AH, Bartolo C, Sedra MS, Western LM, Mendell JR.
    Nat Genet; 1993 Aug 28; 4(4):357-60. PubMed ID: 8401582
    [Abstract] [Full Text] [Related]

  • 20. Dystrophin expression in Duchenne patients with "in-frame" gene deletions.
    Nicholson LV, Bushby KM, Johnson MA, Gardner-Medwin D, Ginjaar IB.
    Neuropediatrics; 1993 Apr 28; 24(2):93-7. PubMed ID: 8327067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.